Cargando…

Pseudolaric Acid A: A Promising Antifungal Agent Against Prevalent Non-albicans Candida Species

PURPOSE: The non-albicans Candida (NAC) species have recently gained great importance worldwide due to the increasing proportion in candida causing bloodstream infections. This investigation aimed to explore the efficacy of Pseudolaric acid A (PAA, a diterpenoid derived from Pseudolarix kaempferi) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhen, Zhu, Bin, Chen, Weiqin, Hu, Jun, Xue, Yingjun, Yin, Hongmei, Hu, Xiaobo, Liu, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494979/ https://www.ncbi.nlm.nih.gov/pubmed/37700797 http://dx.doi.org/10.2147/IDR.S419646

Ejemplares similares

Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition
por: Zhu, Bin, et al.
Publicado: (2022)

Synergistic Effect of Pseudolaric Acid B with Fluconazole Against Resistant Isolates and Biofilm of Candida tropicalis
por: Li, Zhen, et al.
Publicado: (2020)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Promising Antifungal Targets Against Candida albicans Based on Ion Homeostasis
por: Li, Yiman, et al.
Publicado: (2018)

Autophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents
por: Shen, Jiadi, et al.
Publicado: (2023)

Natural Compounds with Antifungal Properties against Candida albicans and Identification of Hinokitiol as a Promising Antifungal Drug
por: Camaioni, Louis, et al.
Publicado: (2023)

Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species
por: Mohammadi, Faezeh, et al.
Publicado: (2021)

In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey
por: Yenisehirli, Gulgun, et al.
Publicado: (2015)

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
por: Ou, Huang-Tz, et al.
Publicado: (2017)

Susceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents
por: Badiee, P, et al.
Publicado: (2016)

Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans
por: ELLEPOLA, Arjuna Nishantha, et al.
Publicado: (2015)

Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
por: Seyoum, Elias, et al.
Publicado: (2020)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Quantitative and Qualitative Analyses of the Cell Death Process in Candida albicans Treated by Antifungal Agents
por: Kim, Kyung Sook, et al.
Publicado: (2011)

In vitro activity of five antifungal agents against Candida albicans isolates, Sari, Iran
por: Shokohi, T, et al.
Publicado: (2016)

Fungistatic Action of N-Acetylcysteine on Candida albicans Biofilms and Its Interaction with Antifungal Agents
por: Nunes, Thaís Soares Bezerra Santos, et al.
Publicado: (2020)

Antifungal activity of hypocrellin compounds and their synergistic effects with antimicrobial agents against Candida albicans
por: Song, Shihao, et al.
Publicado: (2020)

Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis
por: Gharehbolagh, Sanaz Aghaei, et al.
Publicado: (2020)

Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species
por: Bellavita, Rosa, et al.
Publicado: (2022)

WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action
por: Maione, Angela, et al.
Publicado: (2022)

Exploring the Antifungal Activity and Action of Saussurea costus Root Extracts against Candida albicans and Non-albicans Species
por: Soliman, Melad F., et al.
Publicado: (2022)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate
por: K PATHAK, Apurva, et al.
Publicado: (2012)

Antifungal activity of MAF-1A peptide against Candida albicans
por: Cheng, Rong, et al.
Publicado: (2021)

In Vitro Antifungal Activity of Equol against Candida albicans
por: Lee, Jeong Ah, et al.
Publicado: (2010)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Potent Antifungal Activity of Penta-O-galloyl-β-d-Glucose against Drug-Resistant Candida albicans, Candida auris, and Other Non-albicans Candida Species
por: Marquez, Lewis, et al.
Publicado: (2023)

Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents
por: Cheah, Hong-Leong, et al.
Publicado: (2014)

D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
por: Dartevelle, Pauline, et al.
Publicado: (2018)

Use of Haploid Model of Candida albicans to Uncover Mechanism of Action of a Novel Antifungal Agent
por: Truong, Thuyen, et al.
Publicado: (2018)

Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans
por: Huang, Mu-Ching, et al.
Publicado: (2018)

Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans
por: Yang, Feng, et al.
Publicado: (2021)

The Bovhyaluronidase Azoximer (Longidaza(®)) Disrupts Candida albicans and Candida albicans-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals
por: Gatina, Alina, et al.
Publicado: (2022)

Profile susceptibility to fluconazole and voriconazole antifungals by species of Candida albicans isolated from urine culture
por: Wiebusch, Laura, et al.
Publicado: (2014)

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017)

Hsp21 Potentiates Antifungal Drug Tolerance in Candida albicans
por: Mayer, François L., et al.
Publicado: (2013)

Effects of Chitosan on Candida albicans: Conditions for Its Antifungal Activity
por: Peña, Antonio, et al.
Publicado: (2013)

High Virulence and Antifungal Resistance in Clinical Strains of Candida albicans
por: Monroy-Pérez, Eric, et al.
Publicado: (2016)

Antifungal Activity of Oleuropein against Candida albicans—The In Vitro Study
por: Zorić, Nataša, et al.
Publicado: (2016)

Antifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis
por: Jia, Chang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h7de5u9vfc66r02fj88k2uauis